Search results for "Infectious Diseases"
Nirmatrelvir/ritonavir rarely leads to rebound, doesn't help average-risk patients, studies find
A retrospective analysis found that symptom rebound occurred in less than 1% of high-risk COVID-19 patients treated with nirmatrelvir/ritonavir, while the manufacturer reported that the drug didn't show significant benefit in average-risk patients.
https://acpinternist.org/weekly/archives/2022/06/21/2.htm
21 Jun 2022
Register now for ACP and Annals of Internal Medicine's COVID-19 Forum VIII: Outpatient Evaluation and Management of Patients with COVID-19
During the Feb. 9 virtual live event, a panel of experts will discuss appropriate COVID-19 testing, quarantine and isolation periods, management of symptoms, and recommended treatments in the outpatient setting.
https://acpinternist.org/weekly/archives/2022/02/01/2.htm
1 Feb 2022
Register now for ACP and Annals of Internal Medicine's COVID-19 Forum VII: Challenging Clinical Questions
During the Dec. 8 virtual live event, a panel of experts will provide answers to common questions about COVID-19 that physicians face today.
https://acpinternist.org/weekly/archives/2021/11/23/2.htm
23 Nov 2021
Register now for next ACP, Annals of Internal Medicine forum on COVID-19
On Oct. 8, panelists will provide insight on the clinical implications of the immunology of SARS-CoV-2 and the COVID-19 vaccine, including the status of booster doses and the efficacy of vaccination in various groups.
https://acpinternist.org/weekly/archives/2021/10/05/2.htm
5 Oct 2021
ACP, Annals of Internal Medicine host ‘Monkeypox: Challenging Clinical Questions’
The virtual forum featured a panel of physicians providing answers to commonly asked questions about the human monkeypox virus and is available for replay online.
https://acpinternist.org/weekly/archives/2022/10/18/5.htm
18 Oct 2022
New best practice guidance encourages stewardship of urine culture orders
A panel of 15 experts offered recommendations for diagnostic stewardship of urine cultures, including strategies for ordering, processing, and reporting cultures in the ED, hospital, outpatient practice, and long-term care.
https://acpinternist.org/weekly/archives/2021/12/07/6.htm
7 Dec 2021
IDSA releases guidance on antibiotic selection for gram-negative antimicrobial-resistant bacterial infections
New treatment guidance from the Infectious Diseases Society of America (IDSA) focused on extended-spectrum beta-lactamase-producing Enterobacterales, carbapenem-resistant Enterobacterales, and Pseudomonas aeruginosa with difficult-to-treat resistance.
https://acpinternist.org/weekly/archives/2020/09/15/4.htm
15 Sep 2020
New data on COVID-19 vaccines' effectiveness against omicron, among immunocompromised
One English analysis showed how COVID-19 boosters increase protection against symptomatic infection from omicron, while two studies looked at vaccinating the immunocompromised, and ACP videos worked to educate patients and increase vaccine uptake.
https://acpinternist.org/weekly/archives/2022/03/08/2.htm
8 Mar 2022
Clinician education, feedback led to fewer inappropriate antibiotics for respiratory tract infections
A stepped-wedge cluster randomized study in 31 primary care practices found that the proportion of visits with an antibiotic prescription decreased from 35.2% to 23.0% after an intervention involving clinician education and monthly peer comparison feedback.
https://acpinternist.org/weekly/archives/2021/07/13/5.htm
13 Jul 2021
Two studies show effectiveness of mRNA boosters against omicron variant
Other recent research on COVID-19 revealed the high transmissibility of the omicron stealth variant and changes in the brain after SARS-CoV-2 infection.
https://acpinternist.org/weekly/archives/2022/03/15/5.htm
15 Mar 2022